低危女性冠状动脉钙化的患病率与预后意义:一项Meta分析
该Meta分析纳入5项大型人群队列(美国达拉斯心脏研究、弗雷明汉心脏研究、德国海因茨·尼克斯多夫回忆研究、美国多种族动脉粥样硬化研究、荷兰鹿特丹研究)中10年ASCVD风险<7.5%的6739名女性,评估冠状动脉钙化(CAC)与ASCVD事件的关系。中位随访7.0至11.6年,共发生165例ASCVD事件。CAC>0者占36.1%,与CAC=0相比,CAC>0与ASCVD风险升高相关(多变量校正HR 2.04,95%CI 1.44-2.90)。将CAC加入传统危险因素后,C统计量从0.73升至0.77,cNRI为0.20(95%CI 0.09-0.31)。作者认为需要进一步研究评估这一额外准确性的临床效用和成本效益。
要点
- 在10年ASCVD风险<7.5%的低危女性中,CAC>0者占36.1%(6739名女性,5项队列)。
- CAC>0与ASCVD风险升高相关:多变量校正HR 2.04(95%CI 1.44-2.90),CAC=0 vs CAC>0的发病率差为2.92/1000人年(95%CI 2.02-3.83)。
- 将CAC加入传统危险因素后,C统计量从0.73(95%CI 0.69-0.77)升至0.77(95%CI 0.74-0.81),cNRI为0.20(95%CI 0.09-0.31)。
- 作者结论:CAC在低危女性中常见并与ASCVD风险升高相关,但预后准确性改善幅度有限,需进一步研究评估临床效用和成本效益。
适用人群与场景
- 基于美国心脏病学会和美国心脏病协会CVD预防指南评估为低心血管疾病风险(10年ASCVD风险<7.5%)的女性。
- 来自5项大型人群队列:达拉斯心脏研究(美国)、弗雷明汉心脏研究(美国)、海因茨·尼克斯多夫回忆研究(德国)、多种族动脉粥样硬化研究(美国)、鹿特丹研究(荷兰)。
- CAC扫描于1998年至2006年间进行,事件评估截至2012年1月1日、2014年1月1日或2015年3月6日。
诊断标准与关键阈值
- 低危定义:10年ASCVD风险<7.5%(基于美国心脏病学会和美国心脏病协会CVD预防指南)。
- CAC分组:CAC=0(无钙化) vs CAC>0(存在钙化)。
研究设计与关键结果
- 研究类型:固定效应Meta分析,纳入5项大型人群队列,共6739名低危女性,平均年龄范围44至63岁,中位随访范围7.0至11.6年。
- CAC>0者占36.1%;共发生165例ASCVD事件(64例非致死性心肌梗死、29例冠心病死亡、72例卒中),ASCVD发病率范围1.5至6.0/1000人年。
- CAC>0 vs CAC=0:ASCVD发病率1.41 vs 4.33/1000人年,差值2.92(95%CI 2.02-3.83);多变量校正HR 2.04(95%CI 1.44-2.90)。
- 将CAC加入传统危险因素后,C统计量从0.73(95%CI 0.69-0.77)升至0.77(95%CI 0.74-0.81),cNRI为0.20(95%CI 0.09-0.31)。
证据类型、等级与局限
- 证据类型:固定效应Meta分析,汇总5项大型人群队列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在基于美国心脏病学会和美国心脏病协会指南评估为低危(10年ASCVD风险<7.5%)的女性中,CAC>0与ASCVD风险升高相关(多变量校正HR 2.04,95%CI 1.44-2.90),且CAC加入传统危险因素后C统计量从0.73升至0.77、cNRI为0.20(95%CI 0.09-0.31)。
- 作者结论:需要进一步研究评估这一额外准确性的临床效用和成本效益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The role of coronary artery calcium (CAC) testing for guiding preventive strategies among women at low cardiovascular disease (CVD) risk based on the American College of Cardiology and American Heart Association CVD prevention guidelines is unclear.
OBJECTIVE: To assess the potential utility of CAC testing for CVD risk estimation and stratification among low-risk women.
DESIGN, SETTING, AND PARTICIPANTS: Women with 10-year atherosclerotic CVD (ASCVD) risk lower than 7.5% from 5 large population-based cohorts: the Dallas Heart Study (United States), the Framingham Heart Study (United States), the Heinz Nixdorf Recall study (Germany), the Multi-Ethnic Study of Atherosclerosis (United States), and the Rotterdam Study (the Netherlands). The 5 cohorts were selected based on the availability of CAC data in a sizable group of low-risk women from the general population together with the long detailed follow-up data. Across the cohorts, events were assessed from the date of CAC scan (performed from 1998 through 2006) until January 1, 2012; January 1, 2014; or March 6, 2015. Fixed-effects meta-analysis was conducted to combine the results of the 5 studies.
EXPOSURES: CAC score by computed tomography.
MAIN OUTCOMES AND MEASURES: Main outcome was incident ASCVD, including nonfatal myocardial infarction, coronary heart disease (CHD) death, and stroke. Association of CAC with ASCVD was examined using Cox proportional hazards models. To assess whether CAC was associated with improved ASCVD risk predictions beyond the traditional risk factors, the C statistic and the continuous net reclassification improvement (cNRI) index were calculated.
RESULTS: Among 6739 women with low ASCVD risk from the 5 studies, mean age ranged from 44 to 63 years and CAC was present in 36.1%. Across the cohorts, median follow-up ranged from 7.0 to 11.6 years. A total of 165 ASCVD events occurred (64 nonfatal myocardial infarctions, 29 CHD deaths, and 72 strokes), with the ASCVD incidence rates ranging from 1.5 to 6.0 per 1000 person-years. Compared with the absence of CAC (CAC = 0), presence of CAC (CAC >0) was associated with an increased risk of ASCVD (incidence rates per 1000 person-years, 1.41 for CAC absence vs 4.33 for CAC presence; difference, 2.92 [95% CI, 2.02-3.83]; multivariable-adjusted hazard ratio, 2.04 [95% CI, 1.44-2.90]). The addition of CAC to traditional risk factors improved the C statistic from 0.73 (95% CI, 0.69-0.77) to 0.77 (95% CI, 0.74-0.81) and provided a cNRI of 0.20 (95% CI, 0.09-0.31) for ASCVD prediction.
CONCLUSIONS AND RELEVANCE: Among women at low ASCVD risk, CAC was present in approximately one-third and was associated with an increased risk of ASCVD and modest improvement in prognostic accuracy compared with traditional risk factors. Further research is needed to assess the clinical utility and cost-effectiveness of this additional accuracy.
参考来源
- Kavousi M, Desai CS, Ayers C, et al. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA. 2016. PMID: 27846641. doi:10.1001/jama.2016.17020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。